Hormonal Regulation of Puberty and Fertility
NCT01511588 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111
Last updated 2026-05-22
Summary
Background:
\- The body produces gonadotropin-releasing hormone (GnRH) about every 2 hours. GnRH travels through the bloodstream to the pituitary gland, where it stimulates the gland to produce hormones called gonadotropins. These hormones stimulate the testicles or ovaries. The testicles produce testosterone and develop sperm. The ovaries produce estrogen and prepare for ovulation. Normal estrogen and testosterone levels are required for puberty. Some people, however, have either low levels or total lack of GnRH. This can cause problems with puberty and fertility. Researchers want to study people with low or no GnRH to better understand how it affects puberty and fertility.
Objectives:
\- To study disorders of GnRH production.
Eligibility:
* Adult men and women at least 18 years of age with low or no gonadotropin levels.
* Adolescents between 14 and 18 years of age with low or no gonadotropin levels.
Design:
* Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected.
* Participants will have tests to look at their hormone levels. Blood samples may be collected after taking different drugs, including insulin and cortisone. A 24-hour urine sample will be collected.
* Participants will have imaging studies to look at bone and brain development. They will also have ultrasounds of the kidneys, abdomen, and reproductive organs.
* Tests of smell and hearing will be used to look for abnormalities in these senses....
Conditions
- Endocrine Disease
- Infertility
- Hypogonadism
- Amenorrhea
- Adolescents
Sponsors & Collaborators
-
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Principal Investigators
-
Natalie D Shaw, M.D. · National Institute of Environmental Health Sciences (NIEHS)
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-25
Countries
- United States
Study Locations
More Related Trials
-
Kisspeptin Administration in the Adult
NCT00914823 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
NCT01428245 ·Status: TERMINATED ·Phase: NA
-
Gonadotrophin Dosage Using a Threshold Nomogram for Ovulation Induction in WHO Group II Anovulatory Infertility
NCT01250821 ·Status: COMPLETED ·Phase: PHASE4
-
Progesterone Suppression of Nocturnal LH Increases in Pubertal Girls
NCT01773772 ·Status: COMPLETED ·Phase: PHASE1
-
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
NCT07224438 ·Status: RECRUITING ·Phase: PHASE2
-
Triggering of Follicular Maturation
NCT02916173 ·Status: COMPLETED ·Phase: PHASE3
-
Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF
NCT01798836 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
GnRH for Luteal Support in IVF/ICSI/FET Cycles
NCT02357654 ·Status: RECRUITING ·Phase: PHASE4
-
Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation
NCT01606709 ·Status: TERMINATED ·Phase: PHASE4
-
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
NCT05633966 ·Status: COMPLETED ·Phase: PHASE1
-
GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT
NCT03039049 ·Status: COMPLETED ·Phase: PHASE3
-
Reproductive Hormones During Sustained Administration of Kisspeptin
NCT02081924 ·Status: RECRUITING ·Phase: NA
-
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response
NCT03373149 ·Status: UNKNOWN ·Phase: PHASE2
-
Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles
NCT01191710 ·Status: UNKNOWN ·Phase: PHASE4
-
GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT
NCT02053779 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of GnRH Agonist Trigger in the Prevention of OHSS
NCT00349258 ·Status: COMPLETED ·Phase: PHASE4
-
Trigger Timing in Ovarian Stimulations
NCT04163133 ·Status: RECRUITING ·Phase: NA
-
Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program
NCT03237117 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
NCT00929006 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS
NCT01815138 ·Status: COMPLETED ·Phase: PHASE4
-
Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Assisted Reproductive Treatments
NCT06297564 ·Status: COMPLETED ·Phase: NA
-
Intrauterine Human Chorionic Gonadotrophins (hCG) and Endometrial Treg Cells
NCT01064219 ·Status: COMPLETED ·Phase: NA
-
Follicle-Stimulating Hormone (FSH) and the Onset of Puberty
NCT00734279 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures
NCT02048891 ·Status: COMPLETED ·Phase: PHASE4
-
Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency
NCT06851754 ·Status: RECRUITING ·Phase: PHASE3